NPS PHARMACEUTICALS INC Additional Paid in Capital
NPS PHARMACEUTICALS INC had Additional Paid in Capital of $1.17 billion as of 2014-12-31, per its 10-K filed 2015-02-18.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2015-02-18
- 2014-12-31: Additional Paid in Capital $1.17B.
- 2014-09-30: Additional Paid in Capital $1.16B.
- 2014-06-30: Additional Paid in Capital $1.16B.
- 2014-03-31: Additional Paid in Capital $1.13B.
| Period end | Additional Paid in Capital |
|---|---|
| 2014-12-31 | $1.17B 10-K · filed 2015-02-18 |
| 2014-09-30 | $1.16B 10-Q · filed 2014-11-10 |
| 2014-06-30 | $1.16B 10-Q · filed 2014-08-06 |
| 2014-03-31 | $1.13B 10-Q · filed 2014-05-08 |
| 2013-12-31 | $1.13B 10-K · filed 2015-02-18 |
| 2013-09-30 | $1.12B 10-Q · filed 2013-11-06 |
| 2013-06-30 | $1.11B 10-Q · filed 2013-08-08 |
| 2013-03-31 | $1.01B 10-Q · filed 2013-05-09 |
| 2012-12-31 | $954.45M 10-K · filed 2014-02-18 |
| 2012-09-30 | $950.13M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $948.31M 10-Q · filed 2012-08-01 |
| 2012-03-31 | $946.55M 10-Q · filed 2012-05-03 |
| 2011-12-31 | $944.34M 10-K · filed 2013-02-21 |
| 2011-09-30 | $943.21M 10-Q · filed 2011-11-03 |
| 2011-06-30 | $942.04M 10-Q · filed 2011-08-02 |
| 2010-12-31 | $798.84M 10-K · filed 2012-02-15 |